Helicobacter pylori eradication using one‐week low‐dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin

Aim: To evaluate and compare two 1‐week low‐dose triple therapies based on lansoprazole, amoxycillin and a macrolide in eradicating Helicobacter pylori.

[1]  M. Montalto,et al.  Low‐dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. , 1996, Alimentary pharmacology & therapeutics.

[2]  M. Stolte,et al.  One‐week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection , 1996, Alimentary pharmacology & therapeutics.

[3]  M. Montalto,et al.  The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. , 1996, The American journal of gastroenterology.

[4]  J. Misiewicz,et al.  Eradication of Helicobacter pylori with lansoprazole and clarithromycin , 1995, Alimentary pharmacology & therapeutics.

[5]  A. Munakata,et al.  Eradication of Helicobacter pylori with Lansoprazole and Clarithromycin in Gastric Ulcer Patients , 1995, Journal of clinical gastroenterology.

[6]  A. Goddard,et al.  One-week low-dose triple therapy: new standards for Helicobacter pylori treatment. , 1995, European journal of gastroenterology & hepatology.

[7]  F. Bazzoli,et al.  Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori , 1994 .

[8]  D. Graham,et al.  Factors influencing the eradication of Helicobacter pylori with triple therapy. , 1992, Gastroenterology.

[9]  F. Mégraud,et al.  Activity of lansoprazole against Helicobacter pylori , 1991, The Lancet.

[10]  H. Satoh,et al.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori , 1991, Antimicrobial Agents and Chemotherapy.

[11]  A. Burette,et al.  Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. , 1990, The American journal of gastroenterology.

[12]  P. Fernandes,et al.  Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. , 1988, The Journal of antimicrobial chemotherapy.